Profiel
Arvind K.
Sood is Chief Strategy & Corporate Affairs Officer at Coherus Oncology, Inc. since 2025.
Former roles include Executive Vice President & President-US Operations at Innate Pharma SA from 2024 to 2025, Vice President-Investor Relations at Amgen, Inc., and SVP-Investor Relations & Financial Communications at Aventis SA. Education includes an MBA from Central Michigan University and an undergraduate degree from Western Michigan University.
Actieve functies van Arvind Sood
| Bedrijven | Functie | Begin |
|---|---|---|
| COHERUS ONCOLOGY, INC. | Public Communications Contact | 06-11-2025 |
Eerdere bekende functies van Arvind Sood
| Bedrijven | Functie | Einde |
|---|---|---|
| INNATE PHARMA | Corporate Officer/Principal | 03-02-2025 |
Aventis SA
Aventis SA Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals and vaccines for preventative medicine | Investor Relations Contact | - |
| AMGEN INC. | Investor Relations Contact | - |
Opleiding van Arvind Sood
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Aventis SA
Aventis SA Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals and vaccines for preventative medicine | Health Technology |
Central Michigan University
Central Michigan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Western Michigan University
Western Michigan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Innate Pharma SA
Innate Pharma SA Pharmaceuticals: MajorHealth Technology Develops therapeutic antibodies that harness the immune system to improve cancer treatment and clinical outcomes | Health Technology |
Coherus BioSciences, Inc.
Coherus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial-stage biopharmaceutical company that engages in research, development and commercialization of immunotherapies to treat cancer | Health Technology |
















